Alzheimer’s Research & Therapy publishes first research article

Persistence pays off, at least that is the message from Rountree et al. in the first research article published in Alzheimer’s Research & Therapy.  This article, ‘Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer's disease (AD)’ reports their findings that persistent treatment had a positive impact on Alzheimer’s disease (AD) progression by multiple cognitive and functional outcome measures.

Alzheimer’s Research & Therapy publishes basic research with a translational focus, as well as looking at animal models of disease, biomarkers, clinical trials, and research into drug discovery and development. Although the primary focus is Alzheimer’s dementia, the scope will encompass translational research into other neurodegenerative diseases. 

The Editors-in-Chief of Alzheimer’s Research & Therapy are Professors Douglas Galasko, Todd Golde, and Gordon Wilcock, who are supported by an exceptional international Editorial Board.

Submit your next manuscript to Alzheimer’s Research & Therapy to join the pioneering authors who are publishing in this exciting journal. For more details about the journal, please visit the journal information page, or contact the editorial office. To keep up to date with the latest developments, news and articles being published in this exciting, please register to receive regular alerts.

Frances Mulvany
In-house Editor – Alzheimer’s Research & Therapy

Posted by Alison Cobb at 10:54    Comments (0)